The gold mine that is anti-aging technology: Anti-aging advancements in 2022
With the rise of age-related diseases today, researchers are beginning to view aging as a treatable condition. There are growing numbers of biotechnology companies investing in research that could prevent and reverse the aging process. The anti-aging technology industry has also become one of the fastest-growing fields in life science, aiming at increasing life expectancy and improving quality of life.
Below are some of the anti-aging advancements in 2022.
Cellular Rejuvenation Programming (Altos Labs)
Rick Klausner and Hans Bishop, co-founders of Altos Labs, publicly announced their initiative to study aging. Altos aims to streamline an anti-aging technology procedure called cellular rejuvenation programming. They hope to discover new biological pathways that can be targeted with drugs to rejuvenate senescent and old cells without causing cancer.
This startup is among many that are exploring ways to rejuvenate parts of the human body through reprogramming technology. Scientists have been able to revitalize cells in the lab, which some believe can be used to revitalize the entire body of an animal, potentially prolonging the life of humans.
Several studies have demonstrated that cells can rejuvenate by resetting their epigenetic clocks and erasing damage. As a result of these insights, Altos reimagined medical treatments that could reverse disease for patients of any age. Along with achievements in various transformative technologies, the company aims to develop cellular rejuvenation programming and do more research on how it can mitigate or even eliminate aging-related diseases.
Nano-Pulse Stimulation (NPS) is a new anti-aging technology that has been proven effective. According to research, it has treated benign cutaneous lesions and has great potential in treating malignancies.
The purpose of nano-pulse stimulation is to stimulate cellular structures by creating nanopores in the cell's plasma membrane by delivering pulsed electric fields in the ultrashort nanosecond domain.
By delivering NPS energy pulses to a targeted tissue area, NPS alters the structure and function of internal organelles such as the mitochondria.
Additionally, NPS was found to be effective in treating cutaneous non-genital warts in a feasibility study. NPS has also been shown to be safe and effective in treating common benign skin lesions such as seborrheic keratoses and sebaceous hyperplasia.
Senolytics are a class of drugs that rid the body of old, non-dividing cells known as senescent cells. Throughout the body, they collect in tissues and secrete factors that cause damage to other cells. Age-related conditions such as frailty, cognitive impairment, and physical infirmity have been linked to the body's increasing number of senescent cells.
Researchers at the Mayo Clinic say that senolytic drugs can boost a protein in the body that helps protect older people against diseases and the effects of aging.
More research on the use of senolytics and other anti-aging technology is currently underway. One study looks into several senolytic drugs to treat Intervertebral disc degeneration (IVDD). IVDD is the main cause of cervical and lumbar spondylosis.
Two familiar drugs are among the leading candidates for slowing aging: metformin and rapamycin. Metformin is a popular drug used to treat diabetes, while rapamycin has been used to prevent patients from rejecting transplanted organs. Animal studies have shown that both therapies increase longevity and inhibit cellular aging processes.
Check out the clinical trial listings we have at the Dry Powder Bio community today.